ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) is expected to report earnings on February 8, 2027, before the market open. The consensus earnings estimate is a loss of $0.44 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.1% since its last earnings release on November 9, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Roivant Sciences Ltd.
Roivant's mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity.
Sector
Healthcare
Industry
Biotechnology
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.